Imed Infinity Medical-Limited Partnership
Imed Infinity Medical-Limited Partnership, a research and development partnership, focuses on investing in research projects and development in the medical field, primarily the digital health field. Imed Infinity Medical-Limited Partnership was incorporated in 2020 and is based in Tel Aviv, Israel.
Market Cap & Net Worth: Imed Infinity Medical-Limited Partnership (IMED)
Imed Infinity Medical-Limited Partnership (TA:IMED) has a market capitalization of $1.22 Million (ILA455.95 Million) as of March 18, 2026. Listed on the TA stock exchange, this Israel-based company holds position #44611 globally and #440 in its home market, demonstrating a -5.20% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Imed Infinity Medical-Limited Partnership's stock price ILA113.00 by its total outstanding shares 4035000 (4.04 Million).
Imed Infinity Medical-Limited Partnership Market Cap History: 2020 to 2026
Imed Infinity Medical-Limited Partnership's market capitalization history from 2020 to 2026. Data shows change from $10.83 Million to $1.22 Million (-34.21% CAGR).
Imed Infinity Medical-Limited Partnership Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Imed Infinity Medical-Limited Partnership's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
29.39x
Imed Infinity Medical-Limited Partnership's market cap is 29.39 times its annual revenue
1.53x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $3.47 Million | $75.00K | -$766.00K | 46.23x | N/A |
| 2022 | $1.54 Million | $200.00K | -$1.01 Million | 7.69x | N/A |
| 2023 | $1.24 Million | $-942.00K | -$1.77 Million | -1.31x | N/A |
| 2024 | $1.21 Million | $41.00K | -$575.00K | 29.39x | N/A |
Competitor Companies of IMED by Market Capitalization
Companies near Imed Infinity Medical-Limited Partnership in the global market cap rankings as of March 18, 2026.
Key companies related to Imed Infinity Medical-Limited Partnership by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #726 globally with a market cap of $27.95 Billion USD.
- BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ:BTSGU): Ranked #1050 globally with a market cap of $18.65 Billion USD.
- HealthEquity Inc (NASDAQ:HQY): Ranked #2289 globally with a market cap of $6.59 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2365 globally with a market cap of $6.28 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #726 | Veeva Systems Inc Class A | NYSE:VEEV | $27.95 Billion | $185.28 |
| #1050 | BrightSpring Health Services, Inc. Tangible Equity Unit | NASDAQ:BTSGU | $18.65 Billion | $131.16 |
| #2289 | HealthEquity Inc | NASDAQ:HQY | $6.59 Billion | $78.67 |
| #2365 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $6.28 Billion | $39.05 |
Imed Infinity Medical-Limited Partnership Historical Marketcap From 2020 to 2026
Between 2020 and today, Imed Infinity Medical-Limited Partnership's market cap moved from $10.83 Million to $ 1.22 Million, with a yearly change of -34.21%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ILA1.22 Million | -7.30% |
| 2025 | ILA1.32 Million | +9.43% |
| 2024 | ILA1.21 Million | -2.45% |
| 2023 | ILA1.24 Million | -19.63% |
| 2022 | ILA1.54 Million | -55.66% |
| 2021 | ILA3.47 Million | -67.98% |
| 2020 | ILA10.83 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Imed Infinity Medical-Limited Partnership was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.22 Million USD |
| MoneyControl | $1.22 Million USD |
| MarketWatch | $1.22 Million USD |
| marketcap.company | $1.22 Million USD |
| Reuters | $1.22 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.